COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH revenue by segment, product and geography
In its fiscal year ending 2025-12-31, COGNIZANT TECHNOLOGY SOLUTIONS CORP reported revenue across 4 business segments; the largest, Health Sciences, was $6.35B, 30.1% of the filed sum (+7.0% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Health Sciences$6.35B30.1%+7.0% yoy
- Financial Services$6.17B29.2%+7.3% yoy
- Productsand Resources$5.29B25.0%+10.5% yoy
- Communications Mediaand Technology$3.3B15.6%+1.0% yoy
Members sum to the consolidated $21.1B for this period.
- Consulting And Technology Services$13.5B64.1%+8.3% yoy
- Outsourcing Services$7.58B35.9%+4.6% yoy
Members sum to the consolidated $21.1B for this period.
- North America$15.8Bshare n/a+7.4% yoy
- Europe$4.01Bshare n/a+6.7% yoy
- Europeexcluding United Kingdom$2.09Bshare n/a+8.2% yoy
- United Kingdom$1.92Bshare n/a+5.2% yoy
- Restof World$1.32Bshare n/a+2.9% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Financial Services$1.73B31.6%no prior
- Health Sciences$1.57B28.7%no prior
- Productsand Resources$1.32B24.1%no prior
- Communications Media And Technology$854M15.6%no prior
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.